No, atenolol and nebivolol should not be given at the same time.
Two beta-blockers from the same or different subclasses should never be administered together. This is explicitly contraindicated by major hypertension guidelines 1, 2.
Why This Combination is Contraindicated
The 2017 ACC/AHA Hypertension Guidelines clearly state: "Drug combinations that have similar mechanisms of action or clinical effects should be avoided. For example, 2 drugs from the same class should not be administered together (e.g., 2 different beta blockers, ACE inhibitors, or nondihydropyridine CCBs)" 1.
Both atenolol and nebivolol are beta-blockers, though with different properties:
- Atenolol: Cardioselective beta-1 blocker 1
- Nebivolol: Cardioselective beta-1 blocker with vasodilatory properties (nitric oxide-mediated) 1
Despite nebivolol's unique vasodilatory mechanism, they both fundamentally block beta-adrenergic receptors and share overlapping mechanisms of action.
Risks of Combining Two Beta-Blockers
Administering both drugs simultaneously would result in:
- Excessive beta-blockade leading to severe bradycardia
- Profound reduction in cardiac output and myocardial depression
- Increased risk of heart block, particularly in patients with pre-existing conduction abnormalities
- Hypotension from additive blood pressure-lowering effects
- No additional therapeutic benefit since both target the same receptor system
The FDA label for nebivolol specifically warns: "Do not use nebivolol tablets with other β-blockers" 3.
Clinical Approach if Both Are Prescribed
If a patient requires beta-blocker therapy:
- Choose ONE beta-blocker based on specific clinical indications
- For hypertension alone: Either drug is acceptable, though nebivolol may offer advantages in preserving cardiac output and reducing peripheral resistance 4
- For heart failure with reduced ejection fraction: Prefer bisoprolol, carvedilol, metoprolol succinate, or nebivolol 5
- If switching between beta-blockers: Taper the first agent before initiating the second to avoid withdrawal effects and excessive beta-blockade during overlap
Common Pitfall
Do not assume that because nebivolol has vasodilatory properties it can be safely combined with a traditional beta-blocker like atenolol. The shared beta-blocking mechanism makes this combination potentially dangerous and therapeutically redundant.